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Shortened running title: MRI measurement of residual cervical length after radical 
trachelectomy. 
 
Abstract  
Objective: To determine the association between the residual cervix measured on 
post-operative MRI after radical vaginal trachelectomy (RVT) and adverse obstetric 
outcomes. 
Design: Observational study. 
Setting: Referral Cancer centre. 
Population: Women who conceived after RVT for cervical cancer at the Royal 
Marsden Hospital, London, between 1995 and 2015. 
Methods: Post-operative MRI scans were analysed by three researchers. The 
agreement between researchers was assessed by Pearson's correlation coefficient 
and Bland-Altman plot. Patients were divided into two groups (<10mm and ≥10mm 
residual cervix) for the analysis of adverse obstetric outcomes.  
Main outcome Measures: Late miscarriage, premature delivery, premature rupture of 
membranes (PROM) and chorioamnionitis. 
Results: Thirty-one MRI scans were available; 29 of these women had a pregnancy 
that progressed beyond the first trimester. There was a strong reproducibility of the 
measurement of residual cervix (p<0.001). Nineteen women (65.5%) had <10mm and 
10 (34.5%) had ≥10mm residual cervix. Among women with <10mm residual cervix 
seven (36.8%) experienced PROM and ten (66.7%) had a preterm birth; No women 
with ≥10mm residual cervix had PROM and 2 (22.2%) had a preterm birth (p=0.028 
and p=0.035, respectively). Overall, there were nine (16.7%) first trimester 
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miscarriages, six (11.1%) late fetal losses, twelve (31.6%) preterm births and 36 
(66.7%) live births. After a mean follow up of 78.1 months 36 patients were disease-
free and one patient died. 
Conclusions: MRI measurements of the residual cervix are reproducible between 
observers. The incidence of PROM and premature delivery is higher when the residual 
cervix after RVT is less than 10mm.  
 
Funding: The authors have not received any funding to support this study. 
Keywords: Cervical cancer, trachelectomy, fertility sparing treatment, pregnancy 
outcomes, obstetric complications. 
Tweetable abstract: The risk of prematurity after RVT can be predicted from 
measurements of residual cervical length on post-operative MRI scan. 
  
Introduction 
 
Cervical cancer is the fourth most common malignancy in women worldwide [1]. In the 
European Union 20.9% of women with the condition are diagnosed under the age of 40 
while the average age of women who give birth been 30.1 years [2]. Consequently, a 
number of women are diagnosed in their reproductive age. Most of these are early 
stage tumours that can be treated with fertility-preserving procedures such as 
trachelectomy or even cone biopsy depending on the size of the tumour. The most 
studied approach used by most centres worldwide is the radical vaginal trachelectomy 
(RVT) that has proven efficient in terms of obstetric outcomes with a good oncological 
safety profile [3].  
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In recent years there has been discussion about the risk of premature birth and 
other adverse obstetric outcomes in patients undergoing cervical tissue removal 
for treatment of invasive or pre-invasive cervical disease [3,4,5]. Despite 
different opinions in relation to measurements (dimensions, volume) all seem to 
agree that the larger the excision, the greater the risk for adverse obstetric 
results. Premature labour has been observed in 12-28% [6]. The shortening of 
the cervix plays an important role in the risk of premature delivery as shown in 
patients after cone biopsy [5,7]. However, the measurement on the specimen 
excised does not correctly reflect the remaining cervical stroma responsible for 
maintaining the pregnancy to term. This is because the initial length of the 
cervix from where the excised tissue is subtracted is different between patients 
and mainly varies with previous operations on the cervix or cervical trauma and 
previous pregnancies.  
 
MRI is used pre-operatively to determine the dimensions of the tumour, in relation to 
healthy cervical stroma and indicate involvement of the parametrium [4,8,9,10]. 
However, it has not been used routinely post-trachelectomy to assess the risk of 
adverse obstetric outcome. In this study we sought to estimate the risk of adverse 
obstetric outcomes in patients following a RVT for stage 1B1 cervical cancer by 
measuring the length of the residual cervix on a 6-month postoperative MRI scan in 
order to aid future management and counselling of patients post-trachelectomy. 
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Methods 
Women who had a RVT for stage IB1 cervical cancer at the Royal Marsden Hospital, 
London, UK between January 1995 and December 2015 were identified. Fourteen of 
the women included had obstetric outcomes reported as part of a previous publication 
[4]. From this initial population we excluded the patients that never became pregnant or 
tried for a pregnancy or lost to follow up. We included only women that conceived after 
a RVT and their pregnancy completed at least 12 weeks gestation. All included 
patients needed to have a 6-month postoperative MRI scan of the pelvis according to 
the protocol followed at the institution. The clinico-pathological characteristics are 
summarised in Table 1. 
Adverse obstetric outcomes were classified as late miscarriage after 12 weeks 
gestation, premature delivery before 37 weeks of gestation, premature rupture of the 
membranes (PROM) and chorioamnionitis. An elective Caesarian-section at ≥34 weeks 
was not considered an adverse event, as this was a standard recommendation for a 
time in some institutions. Obstetric outcomes were recorded from the letters from 
postoperative appointments in the clinic for the first 10 years, as well as by contacting 
the patients’ General Practitioners when they were lost to follow up or discharged 
before completing 10 years. These are summarised in Table 2. 
The pregnancy rate was defined as the ratio of patients who had at least one 
pregnancy as a function of the total number of patients attempting pregnancy. The live 
birth rate was defined as the ratio of live-birth deliveries to the total number of 
pregnancies achieved. A premature delivery was defined as a delivery <37 weeks’ 
gestation. These deliveries were classified into three categories of prematurity: 24–28 
weeks, 29–33 weeks, and 34–36 weeks. The prematurity rate was defined as the ratio 
of patients who had premature delivery to the total number of pregnancies ending at 
the second and third trimester. 
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Method for the measurement of the residual cervical length: 
Routine post-operative MRI images performed at 6 months follow-up were digitally 
stored and available for analysis. MRI images were analysed by three researchers 
experienced in Gynaecological Oncology imaging. Each individual researcher 
independently identified the best sagittal cervical image that captured the entire 
residual cervical canal and measured the residual cervical length. All three were 
blinded to the pre- and post-operative obstetric outcomes.  
The isthmus of the uterus corresponds to the lower uterine segment and in non-
pregnant women is about 5 mm length and is less muscular than the corpus. It forms 
the junction between the corpus and the cervix. The internal os is situated in the lower 
part of the isthmus (Fig. 1). The isthmus can be identified based on the external 
anatomy of the uterus, as there is a slight constriction with corresponding “waisting” at 
the cervico-uterine junction at the location of the internal os (Fig. 1). Moreover, on T2-
weighted images, the inner layer of intermediate signal intensity in the cervix, which 
corresponds to the endocervical mucosa transitions to a more high signal-intensity 
endometrium. The appearance of the cervical stroma also differs from the myometrium 
being lower in signal intensity. This change in zonal anatomy between cervix and 
uterine body is recognizable.  Although the internal os can be more difficult to identify 
accurately post-trachelectomy as the orientation of the longitudinal axis of the cervix is 
more variable and the anatomy is distorted (Fig. 1), use of anatomical shape and MRI 
features meant that it was identifiable after trachelectomy with adequate accuracy. 
Statistical analysis 
Pearson's correlation coefficient (r) and a Bland-Altman plot were used to evaluate the 
agreement between the researchers measurements of residual cervical length, and 
regression models were used to test if there were correlations between the mean 
difference and average. 
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Values are given as medians and percentages. Differences in patients’ characteristics 
were analysed using Fisher's exact Test. The measurement used for the analysis of 
adverse obstetric outcomes was the mean of the three measurements. Patients were 
divided into two groups. Those with less than 10 mm residual cervical length and those 
with 10 mm residual cervical length or greater. Only the first pregnancy of each patient 
was considered for statistical analysis. Differences between groups were tested using 
the Fisher's exact Test. Events defined as adverse obstetric outcomes included late 
miscarriage after 12 weeks, premature delivery <37 weeks, premature rupture of 
membranes and chorioamnionitis. An elective C-section at ≥34 weeks was not included 
in the analysis of adverse obstetric outcomes. Patients having a first trimester 
miscarriage were excluded from the final analysis. A logistic regression analysis to 
assess the predictive value of the residual cervical length was not performed, as the 
number of patients was too low. P-values <0.05 were considered statistically 
significant. We used the statistical software SPSS 17.0 for Mac for statistical analysis. 
 
Core outcomes measures 
The main outcome of the study was the measurement of the residual cervix 
after RVT for early cervical cancer on the post-operative MRI scan and the 
reproducibility of the method for the measurement between researchers. Other 
outcomes described in the study were the pregnancy results on these patients 
after RVT and the adverse obstetric outcomes, including late miscarriage, 
premature delivery, PROM and chorioamnionitis. The association between the 
residual cervical length measured and the adverse obstetric outcomes was 
analysed.   
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Patient involvement 
Patients were not involved in the design, development or interpretation of this study; 
patients facilitated data about their pregnancy in their follow up appointments. 
 
Funding  
The authors have not received any funding to support this study.  
 
Results 
 
A total of 140 RVT were performed over the period of study. All patients underwent a 
RVT and laparoscopic bilateral pelvic lymph node dissection with preservation of the 
ovaries as treatment for stage IB1 cervical cancer with a cervical cerclage inserted 
previous to the cervico-vaginal anastomosis. All patients were disease-free at the time 
of conception. The clinico-pathological characteristics of the patients are described in 
Table 1. Of the 64 patients who attempted a pregnancy, 37 (57.8%) were identified as 
having achieved a pregnancy. There were 54 pregnancies from the 37 women in total.  
Impacting on subsequent fertility, thirteen of the 64 patients trying to conceive (20.3%) 
were found to have cervical stenosis. Of the women who achieved a pregnancy, eleven 
(29.7%) achieved a pregnancy with the help of assisted reproductive techniques. Nine 
of the 27 patients that were not able to conceive naturally also had unsuccessful IVF. 
The fertility results are reported in Table 2. There were nine (16.7%) first trimester 
miscarriages and six (11.1%) late fetal losses. There were twelve cases of preterm 
birth, with a prematurity rate of 31.6% and a live birth rate of 66.7%. The details of the 
pregnancy outcomes in each patient are described in Table 3. 
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Of the 37 pregnant patients, the 6-month follow-up images were missing in six cases. 
Therefore, 31 MRI scans were analysed.  The Pearson correlation coefficient (r) 
showed a strong positive linear relationship between researcher’s observations 
(r1=0.851, r2=0.906, r3=0.901, p<0.001) indicating the reasonableness of assuming a 
reproducibility of the method. The Bland-Altman plot analysis showed agreement 
between researchers. The estimated mean difference (MD) and standard deviation 
(SD) between the paired measurements and the Bland Altman limits of agreement and 
the linear regression coefficient (R) are detailed as follow: Researcher 1 and 2 
comparison: MD=-0,09, SD=3,11, IC 95%=(5,99)-(-6,18), R=0,258; p=0,019; 
Researcher 1 and 3 comparison: MD=1,86, SD=2,79, IC 95%=(7,34)-(-3,62), R=0,794; 
p=0,030; Researcher 2 and 3 comparison: MD=1,51, SD=2,90, IC 95%=(7,18)-(-4,17), 
R=-0,288; p=0,020. 
Of the 31 patients with post-operative MRI scans available, two had a first trimester 
miscarriage and were therefore excluded from the analysis resulting in 29 patients 
included in the final assessment of cervical length. Patients were divided into two 
groups with residual cervical length <10 mm (n=19) or ≥10 mm (n=10). There were 
seven (36.8%) cases of PROM in the group with <10 mm residual cervix compared to 
no cases in the group of patients with ≥10 mm residual cervix (7/19 (36.84%) vs. 0/10 
(0%) respectively, p=0.032). 
For the premature delivery analysis 24 patients with pregnancies over 22 weeks 
gestation were included. In the group of patients with <10 mm residual cervix, ten 
(66.7%) had a preterm birth compared to two (22.2%) in patients with ≥10 mm residual 
cervix (10/15, 66.7%, versus 2/9, 22.2%, respectively, p=0.045). There were no 
differences for late miscarriage and chorioamnionitis between the two groups (Table 4).  
A total of 36 live births and two fetal deaths occurred. The mean follow-up at the time 
of analysis was 78.1 months (SD 42.4 months, range 17-177 months). At this time 36 
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patients were alive and disease-free and one patient experienced a recurrence seven 
years after diagnosis and died of the disease 56 months after recurrence.  
 
Discussion 
 
Main findings 
 
We have demonstrated that shortening of the cervix following RVT plays an important 
role in the risk of premature delivery. Although this has been shown in pregnant 
patients following cone biopsy [5], its relevance following trachelectomy has not been 
documented. Importantly, this means that the risk of preterm birth after RVT may be 
assessed before pregnancy, which has not previously been described. 
Strengths and limitations 
 
There are few studies investigating the roll of the cervical length in patients after radical 
tracheleclomy. In these studies the measurements of the residual cervix were done 
during pregnancy and performed by ultrasound scan [11,12]. The present study is the 
first reporting data on residual cervix before pregnancy. No other articles analysing 
postoperative MRI scans on trachelectomy patients have been reported in the literature 
until now.   
For many patients included in the last part of the study period, the follow-up time was 
relatively short and therefore most of them had not tried for a pregnancy at the time of 
the analysis. Few years more would give more time for these patients to become 
pregnant and subsequently even more useful data. 
Patients were included over a period of 20 years, and over that time the store of the 
imaging has changed and some of the old MRI imaging were not available for the 
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analysis. The number of patients was not enough for a multivariable analysis. More 
cases are needed in order to assess the predictive value of the residual cervical length 
prior to pregnancy. 
 
Interpretation 
 
The role of residual cervical length in patients after LLETZ on ultrasound done in the 
second trimester of pregnancy has been described [11]. Kasuga et al [12] investigated 
the association between mid-trimester residual cervical length and gestational age at 
delivery after abdominal radical trachelectomy by ultrasound assessment of the 
residual cervix between 21 and 23 weeks’ gestation. They concluded that women with 
a residual cervix shorter than 13 mm had a higher risk of birth before 34 weeks. Pils et 
al [13] further reported the results of a screening program for the prediction of preterm 
delivery in pregnancies after LLETZ, concluding that women with preterm birth had 
lower cervical lengths than those without. Our data not only shows that adverse 
obstetric outcomes can be predicted on measurements made 6 months after RVT, but 
also uses the more robust and repeatable imaging modality of MRI and demonstrates 
the reproducibility of the measurement of residual cervical length between observers.  
RVT has been proven to be a good fertility-sparing treatment for patients with early 
stage cervical cancer with low recurrence rate [3]. Shepherd et al [4] reported a 5-year 
cumulative pregnancy rate of 52.8%. The pregnancy rate in the present study was 
57.8%. The most important obstetric complication after RVT is preterm birth. In a 
recent metanalysis performed by Zhabg et al [3] the miscarriage rate reported was 
18.8%-29.6% and the preterm delivery rate 19.6%-34.2%. Data from our study are 
comparable.  The 61.5% incidence of PROM reported by Ebisawa et al [14] was 
associated with cervical granulocyte elastase and bacterial vaginosis. We do not have 
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information about vaginal infection during pregnancy in our series. Whether routine 
check-ups of vaginal infection in first and second trimester in trachelectomy patients for 
treatment with appropriate antibiotics for the prevention of ascending infection is not 
clear, as other authors have reported that the treatment of bacterial vaginosis in 
asymptomatic pregnant patients does not decrease the incidence of preterm birth [15]. 
No cases of bleeding from the residual cervix in the third trimester or endometritis 
postpartum were reported in our series.  
In addition to the risk of ascending infection, other factors could increase the risk of late 
miscarriage, PROM and preterm birth after trachelectomy. These include insufficient 
mechanical support and the loss of cervical mucus production [16,17]. In these 
patients, the value of preventive cerclage is an unresolved question. Some centres 
prefer to place a preventative cerclage during oncological surgery [18,19,20], as 
cervical cerclage may prevent dilatation of the residual cervix and the subsequent 
PROM and chorioamnionitis [20], whereas other centres prefer that placement to be 
done during pregnancy [21]. 
RVT may also be associated with fertility problems [22,23]. In the present study, 27 
patients were found to be infertile; eleven of them were able to conceive with IVF, nine 
patients underwent no successful IVF procedure. There were thirteen cases of cervical 
stenosis. Plante el at [24] reported fertility problems in 13.5% of the patients that tried 
to conceive, 40% due to cervical factor. It is uncertain how many of these cases had 
fertility problems before trachelectomy.  
 
Conclusion 
This study reveals that the risk of prematurity after RVT can be predicted from MRI 
measurements of residual cervical length on a 6 month post-operative scan and that 
the measurements are reproducible. This is invaluable information for counselling 
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patients that want to conceive after this operation. The incidence of PROM and 
premature delivery is higher when the residual cervix after a RVT is less than 10 mm. 
Surgeons therefore should try to preserve at least 1 cm of the upper cervix when it is 
possible to obtain at least 1 cm clearance of normal tissue surrounding the cervical 
carcinoma in order to allow better obstetric outcomes. 
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Figure legends 
Figure 1. A: Pre-trachelectomy MRI scan. The internal os can be identified as the 
transition point between the mucosa of the endocervical canal and the endometrial 
cavity. B, C and D: Post trachelectomy MRI scans.  
 
Table legends 
Table 1. Clinico-pathological characteristics. 
Table 2. Details of fertility results. 
Table 3. Description of pregnant patients and pregnancy outcomes. 
Table 4. Association between the residual cervical length and subsequent obstetrical 
complications and preterm birth. 
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Table 1. Clinico-pathological characteristics 
 
Total number of women included 37 
Age at diagnosis, mean (range) 30.2 (24-43) 
Histology 
 Adenocarcinoma 
 Squamous carcinoma 
 Adenosquamous 
 
15 (40.5%) 
21 (56.8%) 
1 (2.7%) 
Grade of differentiation 
 Well  
 Moderate 
 Severe 
 Unspecified 
 
10 (27%) 
 13 (35.1%) 
 12 (32.4%) 
  2 (5.4%) 
LVSI 
 Present 
 Absent 
 
10 (27%) 
 27 (73%) 
Preoperative LLETZ 
 Yes 
 No 
 
36 
 1 
Hospital stay (days), mean (range) 6.53 (0-13) 
Follow up (months), mean (range) 78.08 (17-177) 
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Table 2. Details of fertility results. 
 
 N 
Total trachelectomy patients 140 
Patients attempting pregnancy 
       Yes 
       No 
       Unknown 
 
64 
74 
2 
Pregnant patients 
       Natural pregnancy 
       IVF 
37 
26 
11 
Infertile patients 27 
Complications impacting subsequent fertility 
       Cervical stenosis 
       Hematometra 
       Cerclage problems 
       Secondary amenorrhoea 
 
13 
2 
1 
1 
Total number of pregnancies 54 
Fetal loss 1T 9 
Fetal loss 2T 5 
Fetal loss 3T 1 
Termination of pregnancy 2 
Ectopic pregnancy 0 
Preterm delivery  
       Between 22 and 28 weeks 
       Between 29 and 33 weeks 
       Between 34 and 36 weeks 
12 
3 
5 
4* 
Pregnancy rate 57.8%** 
Live birth rate 66.7%*** 
Prematurity rate 31.6%**** 
Total fetal death 2 
Total live birth 36 
 
*Cases with elective Caesarean section at ≥34 weeks were not considered premature 
birth. 
**Ratio of patients who had at least one pregnancy and the total number of patients 
attempting pregnancy.  
***Ratio of live-birth deliveries to the total number of pregnancies achieved. 
****Ratio of premature delivery to the total number of births (n=38). 
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Table 3. Description of pregnancy outcomes. 
 
 Age Conce
ption 
Pregnanci
es after 
RVT (n) 
Type of delivery WG 
1st 
preg 
WG 
2nd 
preg 
Complications/comments 
1 35 natural 6 Elective CS 37 37 CS at 37 WG in 3 pregnancies. 
Three 1T miscarriages later 
2 43 natural 1 - 1T  1T miscarriage 
3 31 natural 2 Elective CS 35 37 - 
4 27 IVF 2 1
st
 Emergency CS 
2
nd
 Elective CS 
34 38 PROM at 34 WG 
5 36 natural 1 Elective CS 37  - 
6 34 natural 1 Elective CS 36  - 
7 27 IVF 3 1
st
 elective CS 
2
nd
 Emergency 
CS 
39 33 Preterm birth in 2
nd
 preg. Termination 
due to trisomy 21 in 3
rd 
at 21 WG. 
8 38 IVF 1 - 35  PROM, corioamnionitis, fetal death 
9 30 natural 1 Emergency CS 34  Preterm birth 
10 35 natural 1 - 1T  7 WG miscarriage 
11 32 natural 2 1
st
 Emergency CS 
2
nd
 Elective CS 
34 38 PROM at 33 WG, CS at 34 WG 
12 30 natural 2 Elective CS 37 37 - 
13 29 natural 3 Elective CS 37  Two 1T miscarriage after baby 
14 31 natural 2 1
st
 Emergency CS         
2
nd
 Elective CS 
33 34 PROM in 1
st
 preg 
15 29 natural 1 Elective CS 37  - 
16 31 natural 1 Emergency CS 19  PROM at 17 WG, chorioamnionitis 
and cord prolapse at 18 WG, late 
miscarriage one week later 
17 26 IVF 1 Vaginal delivery 24  Preterm birth, fetal death 
18 29 IVF 1 Elective CS 35  - 
19 34 natural 3 Elective CS 37+1 1T 11 WG miscarriage in 2
nd
, 
termination due to malformation in 3
rd 
20 30 IVF 1 Emergency CS 27  Preterm birth 
21 35 IVF 1  1T  1T miscarriage 
22 26 natural 1  12  Late miscarriage 
23 27 natural 1 Vaginal delivery 27  PROM. Preterm birth 
24 37 IVF 2 Elective CS 38 37 - 
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25 28 IVF 1  21  Late miscarriage 
26 27 natural 1 Elective CS 38  - 
27 26 natural 1  16  Late miscarriage 
28 26 natural 1 Emergency CS 33  Preterm birth 
29 24 IVF 1 NVD twins 36  - 
30 30 natural 1 Elective CS 36  - 
31 30 IVF 1 Emergency CS 32+4  Fetal distress 
32 25 natural 1 Elective CS 34  -  
33 33 natural 1 Elective CS 38  - 
34 25 natural 1 Elective CS 39  - 
35 28 natural 1 Emergency CS 32  PROM at 26 WG, got 32 WG 
36 25 natural 1 Elective CS 35  - 
37 28 natural 1  14  Late miscarriage 
 
Preg: Pregnancy 
CS: Caesarean section 
PROM: Premature rupture of membranes 
WG: weeks’ gestation  
1T: first trimester 
IVF: In vitro fertilization 
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Table 4. Association between the residual cervical length and  
subsequent obstetrical complications and preterm birth. 
 
 <10 mm length 
(n=19) 
≥10 mm length 
(n=10) 
p 
Late miscarriage 4/19 (21.05%) 1/10 (10%) 0.424a 
PROM 7/19 (36.84%) 0/10 0.032a 
Premature 
delivery* 
10/15 (66.7%) 2/9 (22.2%) 0.045a 
Chorioamnionitis 2/19 (10.53%) 0/10 0.421a 
Any pregnancy 
complication 
14/19 (73.68%) 3/10 (30%) 0.030a 
 
                   aFisher's exact Test 
    For this analysis patients with 1T miscarriage have been excluded (included n=29).  
    
*
For the premature delivery analysis patients with pregnancies over 22 WG have been   
    included only (included n=24). 
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